Ehsan Rajabirostami

Ehsan Rajabirostami practices at Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health.

Ehsan Rajabirostami's NPI, 1932572039, was assigned on November 11, 2015. Ehsan Rajabirostami holds North Carolina license 2018-02778.

Ehsan Rajabirostami's primary practice is Sentara Norfolk General Hospital, at 600 Gresham Dr, Norfolk, VA 23507 in Norfolk City. The practice phone is (757) 388-3000.

Ehsan Rajabirostami's primary practice is Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health. The medical group on file is Sentara Medical Group. Dmand AI also links Ehsan Rajabirostami to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ehsan Rajabirostami practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ehsan Rajabirostami's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Ehsan Rajabirostami's licenses on file in 2 states: North Carolina and Virginia.

CMS data shows 882 Medicare services from Ehsan Rajabirostami across 6 procedure codes in 2024, for 242 Medicare patients. Medicare paid $72,951 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 242 Medicare patients who saw Ehsan Rajabirostami in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ehsan Rajabirostami's median patient age at 64, with 49% women.

In 2024, Ehsan Rajabirostami wrote 373 Medicare Part D claims for 128 patients. 85% of them were for generic drugs. CMS names the drug for 162 of them, across 12 drugs with 11 or more claims each, at $15,261 in total drug cost. In 2023, CMS named 101 claims across 7 drugs.